BIOMAT Database Logo BIOMAT Database Logo

Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. 1985

D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017137 Nonoxynol Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams. Nonylphenoxypolyethoxyethanols,Advantage-S,Delfen Cream,Emulgen 911,Emulgin 913,Nonoxinol,Nonoxinols,Nonoxynol, 1(4)-Sulfate, Sodium Salt,Nonoxynol, 4-Sulfate, Ammonium Salt,Nonoxynol-9,Nonoxynols,Nonylphenoxypolyethoxyethanol,Patentex Oval,Advantage S,Delfen Creams,Nonoxynol 9,Oval, Patentex
D017977 Deltaretrovirus A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE. BLV-HTLV Viruses,HTLV Viruses,HTLV-BLV Viruses,Human T-Cell Leukemia Viruses,Human T-Cell Leukemia-Lymphoma Viruses,Leukemia Viruses, Human T-Cell,T-Cell Leukemia Viruses, Human,Human T Cell Leukemia Lymphoma Viruses,Human T Cell Leukemia Viruses,Leukemia Viruses, Human T Cell,T Cell Leukemia Viruses, Human,BLV HTLV Viruses,HTLV BLV Viruses
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobex.
January 1985, Lancet (London, England),
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
June 1986, Journal of immunology (Baltimore, Md. : 1950),
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Nonoxynol-9 and HTLV-III.
May 1986, Lancet (London, England),
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Disinfection and inactivation of HTLV-III/LAV.
May 1986, The Journal of infectious diseases,
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Inactivation of HTLV-III/LAV during plasma fractionation.
November 1985, Lancet (London, England),
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Granulopoietic precursors in hemophiliac patients infected by HTLV-III/LAV.
July 1987, American journal of clinical pathology,
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
[Inactivation of HTLV-III/LAV by UV irradiation and chemical disinfection].
August 1986, Klinische Monatsblatter fur Augenheilkunde,
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation.
January 1987, Archives of virology,
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
[In vitro diagnosis and anti-LAV/HTLV III].
December 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
D R Hicks, and L S Martin, and J P Getchell, and J L Heath, and D P Francis, and J S McDougal, and J W Curran, and B Voeller
Inactivation of HIV by nonoxynol-9.
March 1988, Lancet (London, England),
Copied contents to your clipboard!